- September 9, 2018How countries can curb antibiotic resistance.
The Economic Times– September 9, 2018. “The study, led by researchers from the Centre for Disease Dynamics, Economics and Policy (CDDEP), here, showed that better infrastructure and better governance were significantly associated with lower measures of antimicrobial resistance.”
Read moreRead more Read More
- September 9, 2018Antimicrobial resistance can’t be tackled by just reducing antibiotics consumption.
Great Lakes Ledger– September 9, 2018. “The research, carried out by researchers at the Center for Disease Dynamics, Economics and Policy (CDDEP), demonstrated that improved governance and infrastructure are strongly linked to lower levels of AMR (Antimicrobial Resistance).”
Read moreRead more Read More - September 6, 2018Good governance, clean water, & sanitation necessary to curb global antibiotic resistance
New analysis shows countries with higher corruption and less spending on public health infrastructure have higher rates of antibiotic resistance.
Read moreRead more Read More - September 5, 2018Not just antibiotic abuse, corruption, low health spend also fuel superbugs.
Hindustan Times– September 5, 2018. ‘Lowering of antibiotic consumption is not sufficient because the spread of resistant strains and resistance genes are the dominant contributing factor. Providing sanitation, clean water and good governance, increasing public health expenditure and better regulating the private health sector are all necessary to reduce antimicrobial resistance,’ said study co-author Ramanan Laxminarayan.
Read moreRead more Read More - August 30, 2018FDA issues warning on common antibiotic class.
Medi Bulletin– August 30, 2018. “According to a study published by Ramanan Laxminarayan et al. titled Antibiotic Resistance in India: Drivers and Opportunities for Action, fluoroquinolones consumption is high and increasing in India. In 2010, India was the world’s largest consumer of antibiotics for human health. The study also found resistance to fluoroquinolones among invasive Salmonella typhi […]
Read moreRead more Read More - August 14, 2018India is rolling out a health-care plan for half a billion people. But are there enough doctors?
The Washington Post– August 14, 2018. The private sector expects huge profits when investing in health care, said Ramanan Laxminarayan, director at the Center for Disease Dynamics, Economics and Policy, and the government’s budget constraints simply won’t be able to match their expectations. “The private sector wants more money than the government wants to spend,” he […]
Read moreRead more Read More - August 7, 2018Just Rs 147 to help protect a kid from diseases in India.
Hindustan Times– August 7, 2018. “‘There’s been a four-fold increase in the immunization budget over the last four years, yet no proper economic costing study has been done. This study is significant because with the addition of more life-saving vaccines, as it should happen, the budget will go up further,’ said study co-author Ramanan Laxminarayan from Princeton […]
Read moreRead more Read More - August 6, 2018Researchers detail variation in costs of child vaccination program in Indian states
Accurate and current costs of delivering routine childhood vaccines in India are needed to budget for future growth.
Read moreRead more Read More - July 1, 2018The startups waging war against superbugs.
The Spokesman-Review– July 1, 2018. “‘The science is as good as anywhere else,’ said Ramanan Laxminarayan, a professor at Princeton University and director of the Center for Disease Dynamics, Economics & Policy, based in Washington and New Delhi. ‘On a per-dollar basis, I think the chance of a new antibiotic discovery is as great or higher […]
Read moreRead more Read More
News
One Health Trust’s work and researchers are featured in international media outlets. Find resources to help understand OHT’s work.
